Notice of Intent to Sole Source - Ortho-Clinical Blood Cards Reagent -
ID: 24-RHCO-C-373Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/81d34767894b4a2db197f0f424ca606f/view
Timeline
    Description

    The Department of Defense, specifically the Army Health Contracting Activity, intends to award a sole source contract to Ortho-Clinical Inc. for the procurement of red blood cell reagent cards necessary for the Government-owned Ortho Vision ID-MTS Workstation analyzer at Irwin Army Community Hospital in Fort Riley, Kansas. This procurement is classified as sole source due to the unique proprietary nature of the required supplies, which are exclusively produced by Ortho Clinical Diagnostics and have a short expiration period, necessitating timely acquisition. The contract is expected to be awarded on or about September 17, 2024, with funding anticipated from FY 2025, and interested parties may direct inquiries to Perry J. Cannon at perry.j.cannon.civ@health.mil.

    Point(s) of Contact
    Perry J. Cannon
    perry.j.cannon.civ@health.mil
    Files
    Title
    Posted
    LSJ - 24-RHCO-C-373_Redacted.pdf
    The memorandum outlines a justification for limiting competition for a procurement action by the Medical Readiness Contracting Office – West. The purpose is to acquire red blood cell reagent cards for the Ortho Vision ID-MTS Workstation used at Irwin Army Community Hospital, with estimated funding from FY 2025. The procurement is classified as a sole source due to the unique proprietary nature of the required supplies, produced exclusively by Ortho Clinical Diagnostics. The rationale includes urgency and exclusive licensing, as these reagents have a short expiration period and cannot be replenished in bulk. Market research confirmed that alternatives are not available through standard government suppliers. A Notice of Intent to Award Sole Source will be published to maintain transparency. The memo concludes with certifications from both the contracting officer and technical staff affirming that the justification for this procurement action is complete and accurate.
    Lifecycle
    Title
    Type
    Notice of Intent to Sole Source - Ortho-Clinical Blood Cards Reagent -
    Currently viewing
    Special Notice
    Similar Opportunities
    Notice of Intent - Ortho Clinical Reagents and Supplies
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a fixed-price contract for Ortho Clinical reagents and supplies, specifically for the Department of Transfusion Medicine at the NIH Clinical Center in Bethesda, Maryland. This procurement aims to secure essential analyzer supplies and reagents that are critical for ensuring the safety and effectiveness of blood products used in transfusion therapy, which must meet specific compatibility requirements for patient treatment. The selected supplier, Ortho-Clinical Diagnostics, Inc., is the sole source for these unique reagents, which have undergone extensive validation studies and are necessary for compatibility testing of both patients and blood donors. Interested parties capable of providing similar products may submit a capability statement by September 22, 2024, to Sheri Eiri at sheri.eiri@nih.gov, as the contract is contingent upon the availability of FY2025 funding.
    Kidney Reagents for Luminex 3D Analyzer
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract for Kidney Reagents for the Luminex 3D Analyzer, specifically for the Kidney Transplant Clinic at The Walter Reed National Military Medical Center in Bethesda, Maryland. The procurement aims to secure molecular and serological reagents from One Lambda Inc. that are essential for transplant testing, ensuring compatibility and reducing the risk of organ rejection between donors and recipients. These reagents are critical as they have been validated by the American Society of Histocompatibility and Immunogenetics (ASHI) and are necessary for maintaining the accreditation of the Immunology Lab. Interested parties may express their interest and provide a capability statement to Barbara Sonnier at barbara.n.sonnier.civ@health.mil by September 24, 2024, at 10:00 PM EST.
    Intent to sole source Biomerieux Vitek2 Preventative maintenance and Consumables
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract to Biomerieux Japan Ltd. for the supply of specific VITEK 2 test cards and annual preventive maintenance services for the U.S. Naval Hospital Yokosuka and Branch Health Clinic Iwakuni in Japan. The procurement includes a delivery schedule spanning fiscal years 2025 to 2027, detailing quantities for three types of test cards essential for laboratory analyses, along with maintenance for two Vitek 2 Compact Analyzers. This contract is critical for ensuring effective healthcare delivery to U.S. Forces Japan personnel, and interested vendors may submit technical capability statements by 07:00 a.m. Pacific Time on 23 September 2024, to Raphael Badagbor at raphael.k.badagbor.civ@health.mil, as no competitive proposals will be solicited.
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    6550--VISN Multiplex PCR Testing Reagents/Consumables Intent to sole source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Great Lakes Acquisition Center, intends to negotiate a sole source contract with BioMerieux, Inc. for the provision of proprietary reagents and consumables necessary for PCR testing on government-owned devices across facilities in Wisconsin, Illinois, and Michigan. This procurement is essential to ensure that the VA can maintain high-quality healthcare services, as only BioMerieux is deemed capable of meeting the specialized requirements for these supplies. The contract will be established as a Blanket Purchase Agreement (BPA) under an existing contract, categorized as firm fixed price, and is being conducted in accordance with FAR 8.405-6. Interested firms must submit their qualifications and relevant customer references to the Contracting Officer, Teresa Beers, at teresa.beers@va.gov within seven calendar days from the publication date of this notice, as no competitive proposals will be solicited.
    CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is planning to issue a sole source award contract to Roche Diagnostics Corporation for the Chemistry and Immunoassay Testing Program. This program is intended to sustain the use of three Chemistry and Immunochemistry Systems under a Cost Per Reportable Result (CPRR) agreement or Cost Per Reagent Pack. The program includes equipment, reagents, tools, materials, training, and a water purification system, Uninterruptible Power Supply (UPS), and services necessary to meet the Chemistry and Immunochemistry testing and analysis requirements for Walter Reed National Military Medical Center (WRNMMC) laboratories. The anticipated period of performance is five years.
    6550--VISN 6 BioFire FilmArray Verification Kits.
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to negotiate a sole source contract for the procurement of BioFire FilmArray Verification Kits from Biomerieux, Inc., to meet the specialized needs of the Veterans Integrated Service Network (VISN) 6. The contract will include various diagnostic panels, with specific quantities required for each type, ensuring that the VA can provide timely and effective medical services to veterans. This procurement is critical as these specialized diagnostic supplies are only available from a single source, emphasizing the importance of maintaining compliance with federal regulations and the efficient delivery of healthcare services. Interested firms may express their capabilities to the Contract Specialist, LaToya Glover, via email by September 23, 2024, with the contract expected to be awarded effective October 1, 2024.
    Notice of Intent to Sole-Source - Hematology Analyzer Services
    Active
    Dept Of Defense
    The Department of Defense, specifically the 341st Contracting Squadron at Malmstrom Air Force Base in Montana, intends to award a sole-source contract to Sysmex America, Inc. for routine preventative maintenance services and reagents for the Sysmex Hematology Analyzer Unit. This procurement is critical as the analyzer requires specific reagents that are exclusively provided by Sysmex America, making them the only viable source for fulfilling this requirement. Interested parties may submit a capability statement or proposal demonstrating why competitive bidding would be advantageous, with submissions due by 14 October 2024 at 2:00 PM MST. For further inquiries, contact SSgt Kevin Luccitti at kevin.luccitti@us.af.mil or SSgt Joshua Crist at joshua.crist.1@us.af.mil.
    Medical Reagents for USNH Okinawa
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) Troop Support Pacific is conducting a sources sought announcement to identify local sources capable of providing medical laboratory reagents for the United States Naval Hospital (USNH) in Okinawa, Japan. The procurement involves the delivery of CLASS VIII medical laboratory reagents, including Ortho reagents and consumables compatible with VITROS 5600 Analyzers, along with necessary training and maintenance services for the equipment. This opportunity is critical for ensuring the availability of essential medical supplies and maintaining compliance with healthcare standards in a military setting. Interested parties must submit their qualifications and relevant information by September 30, 2024, to the primary contacts, Bradley Ah Nee and Arlene Renner, via email at bradley.ahnee@dla.mil and arlene.renner@dla.mil, respectively. The estimated contract value is under $5.4 million, covering a base period of 12 months with two optional periods.
    6640--Benchtop flow cytometer Intent to Sole Source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 6, intends to award a sole source Firm-Fixed-Price purchase order for an Accuri C6 Plus system from Becton, Dickinson and Company (BD Biosciences). This procurement is aimed at acquiring specialized instruments intended solely for research purposes, not for diagnostic or therapeutic use, highlighting the need for proprietary equipment in the VA's operational framework. Interested parties are invited to demonstrate their capability to meet this requirement by submitting supporting evidence by September 20, 2024, at 4 PM EST, with all inquiries directed to Contracting Officer Jamie Sullivan via email at jamie.sullivan4@va.gov.